SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001654954-18-004519
Filing Date
2018-04-30
Accepted
2018-04-30 16:00:24
Documents
4
Period of Report
2018-06-13
Effectiveness Date
2018-04-30

Document Format Files

Seq Description Document Type Size
1 DEF14A tgtx-DEF14A2018.htm DEF 14A 657105
2 IMAGE logo.jpg GRAPHIC 3994
3 IMAGE proxycardimage1.jpg GRAPHIC 99855
4 IMAGE proxycardimage2.jpg GRAPHIC 82612
  Complete submission text file 0001654954-18-004519.txt   904794
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32639 | Film No.: 18789532
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences